Annan naturvetenskaplig och teknisk forskning och utveckling i Stockholm SNI 72109
I annan naturvetenskaplig och teknisk forskning och utveckling i Stockholm kommun finns 315 aktiebolag med årsredovisningsdata. Visar plats 101–200, sorterade på omsättning.
315
aktiebolag
3502.0 M
kr i samlad omsättning
716
anställda
4.1%
median rörelsemarginal
Bolag i Stockholm — plats 101–200 efter omsättning
| # | Bolag | Omsättning | Rörelseresultat | Marginal | Anställda |
|---|---|---|---|---|---|
| 101 | Medi - Tec Research & Development Stockholm AB | 647.1 k | 56.3 k | 7.8% | — |
| 102 | SOOR AB | 645.3 k | 242.5 k | 37.6% | 1 |
| 103 | Tovner AB | 618.1 k | 8.8 k | 1.4% | — |
| 104 | Stella Polaris AB | 613.0 k | 68.7 k | 11.2% | 1 |
| 105 | PINATA AB | 600.0 k | 325.8 k | 54.3% | 1 |
| 106 | FBM Lab Konsult AB | 589.5 k | 392.7 k | 66.6% | 1 |
| 107 | AKTIEBOLAGET BROR BORG | 537.7 k | -328.5 k | -61.1% | 0 |
| 108 | Entymem produktion AB | 531.0 k | 207.8 k | 39.1% | 1 |
| 109 | Science N' Words & Beyond AB | 527.3 k | -20.6 k | -3.9% | 1 |
| 110 | Hakansson Photonics AB | 517.3 k | 191.1 k | 36.9% | 1 |
| 111 | NEUROINFO I STOCKHOLM AB | 513.7 k | 213.4 k | 41.5% | — |
| 112 | AGRONOMICS SCANDINAVIA AB | 512.1 k | -6.3 k | -1.2% | 1 |
| 113 | Data Vigilance Consulting AB | 485.7 k | 218.0 k | 74.2% | 1 |
| 114 | JoY Pharma AB | 482.0 k | 96.2 k | 20.0% | 1 |
| 115 | Medicinsk Promotion Stockholm AB | 435.0 k | 33.8 k | 7.8% | — |
| 116 | Inference Labs AB | 418.3 k | -1.4 M | -165.3% | 1 |
| 117 | JAndlin Consulting AB | 383.0 k | 75.4 k | 19.7% | 1 |
| 118 | ENJ COLAB Aktiebolag | 367.2 k | 285.9 k | 77.9% | — |
| 119 | Arnsvik-Malmberg Konsult AB | 340.8 k | 135.4 k | 39.7% | 1 |
| 120 | TeraSi AB | 339.0 k | -10.6 M | -115.8% | 11 |
| 121 | Molssonbirgersson AB | 337.5 k | 299.6 k | 88.8% | 1 |
| 122 | Aquabiota water research ABWR AB | 317.7 k | -61.5 k | -19.4% | 0 |
| 123 | ASTUDILLO MEDICAL AKTIEBOLAG | 309.5 k | 65.3 k | 21.1% | 1 |
| 124 | Calda AI AB | 300.0 k | -103.3 k | -34.4% | 2 |
| 125 | P3S - Patient Safety Surveillance Solutions AB | 270.0 k | -13.5 k | -4.8% | 1 |
| 126 | Bradley Konsult AB | 268.1 k | -19.5 k | -7.3% | 1 |
| 127 | Jallow Consulting AB | 257.0 k | 248.7 k | 96.8% | — |
| 128 | SEMAIR DIAGNOSTICS AKTIEBOLAG | 252.9 k | -1.2 k | -0.5% | 2 |
| 129 | Hidden in Grains AB | 241.8 k | -177.7 k | -54.6% | 1 |
| 130 | CLINICAL GENE NETWORKS AB | 237.4 k | -1.2 M | -430.1% | — |
| 131 | Magnephy AB | 234.0 k | 226.6 k | 43.7% | 1 |
| 132 | Silicon Witchery AB | 214.2 k | -774.0 k | -204.7% | 2 |
| 133 | MEDIMAX AKTIEBOLAG | 208.2 k | 165.0 k | 79.3% | 0 |
| 134 | Svenningsson NeuroCure AB | 206.2 k | 86.1 k | 29.1% | — |
| 135 | J.P. ZETTERSTRÖM ENDORA AKTIEBOLAG | 203.0 k | -160.3 k | -49.5% | — |
| 136 | EFR Consulting AB | 196.8 k | 174.8 k | 88.8% | — |
| 137 | Böttiger Medical Consulting AB | 189.1 k | 57.8 k | 30.6% | 0 |
| 138 | Pharmolys AB | 174.8 k | -75.0 k | -42.9% | — |
| 139 | CBD Solutions AB | 160.0 k | -22.8 k | -14.3% | — |
| 140 | MERW Medical AB | 157.8 k | -217.3 k | -137.6% | 1 |
| 141 | Tangar Technologies AB | 144.8 k | -1.4 M | -178.2% | 2 |
| 142 | Sciensium AB | 135.0 k | 106.3 k | 78.7% | — |
| 143 | Arandi Innovation AB | 126.2 k | -49.0 k | -38.8% | 1 |
| 144 | Rehn Nordic Consulting AB | 119.5 k | 69.9 k | 58.5% | 1 |
| 145 | Medipal Solutions AB | 113.2 k | 40.0 k | 17.8% | 1 |
| 146 | Curara AB | 104.4 k | -175.1 k | -167.8% | 0 |
| 147 | INSPIRA MEDICAL AB | 101.0 k | 2.8 k | 2.8% | 0 |
| 148 | Cenesy AB | 100.0 k | -423.1 k | -423.1% | 0 |
| 149 | Ursapiens Scientific AB | 100.0 k | 93.6 k | 93.6% | — |
| 150 | 111 37 AB | 90.0 k | -7.3 k | -5.1% | 1 |
| 151 | Coronis and Asklepios Cancer Research AB | 84.9 k | 59.7 k | 70.3% | — |
| 152 | CROSEIR AB | 75.0 k | 56.3 k | 75.0% | — |
| 153 | Biol Aktiebolag | 60.4 k | 39.6 k | 65.5% | 1 |
| 154 | Ce&Ce4med AB | 59.8 k | 106.0 k | 87.2% | 0 |
| 155 | Widigruppen AB | 58.7 k | 21.0 k | 35.7% | — |
| 156 | Silvestria Utveckling Aktiebolag | 58.3 k | 56.7 k | 76.3% | — |
| 157 | Haru AB | 54.0 k | -103.6 k | -191.9% | — |
| 158 | PER-ERIK MOHLIN AKTIEBOLAG | 50.0 k | -274.2 k | -548.4% | — |
| 159 | Jerzy Van der Lux & Partners AB | 50.0 k | 26.9 k | 53.8% | — |
| 160 | MedInArt AB | 46.7 k | 2.0 k | 4.3% | — |
| 161 | Bioplanum AB | 46.4 k | -85.8 k | -185.1% | 1 |
| 162 | CMO MedSupport AB | 45.5 k | -63.0 k | -138.5% | 0 |
| 163 | AB Midgård property management | 42.0 k | 31.8 k | 75.9% | 0 |
| 164 | Vertigocatcher Diagnostics AB | 40.1 k | -330.6 k | -823.9% | — |
| 165 | FFT Medical AB | 40.0 k | -46.8 k | -117.0% | — |
| 166 | CaroAnd Consulting AB | 35.0 k | -15.0 k | -42.8% | 0 |
| 167 | Lennart Högman AB | 31.8 k | 15.5 k | 48.7% | 1 |
| 168 | MEDECT CLINICAL TRIALS AB | 28.9 k | -1.1 M | -3721.0% | — |
| 169 | Camber Consulting AB | 22.0 k | -567.2 k | -2578.3% | 1 |
| 170 | Agents for Health Europe AB | 20.1 k | 2.5 k | 12.7% | — |
| 171 | Kopek Nihlmark AB | 18.8 k | -874.2 k | -4662.4% | — |
| 172 | Levo Prevention AB | 18.4 k | 11.5 k | 62.7% | 0 |
| 173 | PRENUTKI AB | 18.2 k | -48.2 k | -265.0% | — |
| 174 | To Do Medico AB | 16.7 k | -2.3 k | -13.8% | — |
| 175 | IW Nordic AB | 13.2 k | -66.7 k | -505.1% | — |
| 176 | Humorism consulting AB | 12.7 k | -13.1 k | -103.5% | — |
| 177 | Pharmalita AB | 12.5 k | -106.0 k | -845.9% | 1 |
| 178 | Veniatis AB | 11.9 k | -26.1 k | -219.6% | 0 |
| 179 | Heldicon AB | 11.5 k | -14.0 k | -121.5% | 1 |
| 180 | Remy Waardenburg AB | 10.0 k | 2.7 k | 27.4% | — |
| 181 | Duck Capital AB | 8.0 k | -64.5 k | -805.8% | 1 |
| 182 | ZEKELON AKTIEBOLAG | 7.3 k | -16.0 k | -219.3% | — |
| 183 | Adam Carstens AB | 5.0 k | 500 | 10.0% | — |
| 184 | Bright Materia AB | 5.0 k | -416.2 k | -22.9% | 2 |
| 185 | Mimer Energy AB | 3.4 k | -42.4 k | -1255.6% | — |
| 186 | Lufwa & Dufwa Invest AB | 150 | -20.1 k | -13388.7% | — |
| 187 | VITALINE SCANDINAVIA AKTIEBOLAG | 0 | -15.9 k | — | — |
| 188 | Hultström Equity Group AB | 0 | 0 | — | — |
| 189 | DICAN AKTIEBOLAG | 0 | 0 | — | — |
| 190 | AKTIEBOLAGET XIPHOIDEUS | 0 | -62.6 k | -14.2% | 1 |
| 191 | Pipek Aktiebolag | 0 | -184.6 k | — | 1 |
| 192 | MINBAS AB | 0 | 996 | — | — |
| 193 | SOMMAR & SANDSTRÖM AKTIEBOLAG | 0 | 4.2 M | 96.0% | 0 |
| 194 | Lantmännen Medical AB | 0 | -3.1 M | — | — |
| 195 | OxyPharma AB | 0 | -17.7 k | — | — |
| 196 | MicroClone Genomics Sweden AB | 0 | -398.9 k | -120.5% | 2 |
| 197 | Claes Frostell Research and Consulting Aktiebolag | 0 | -1.2 M | — | 1 |
| 198 | Svenska Ankornas Sällskap AB | 0 | -2.9 k | — | 0 |
| 199 | ATTGENO AB | 0 | -7.7 M | -10980.8% | 2 |
| 200 | Oncolution AB | 0 | -75.7 k | — | — |
101–200 av 315 bolag · sida 2 av 4